Kristin Yarema Atara Biotherapeutics, Inc. (ATRA) insider trading activity

ATRA Quotes by TradingView

Kristin Yarema is Chief Commercial Officer of Atara Biotherapeutics, Inc.. Currently has a direct ownership of 171,415 shares of ATRA, which is worth approximately $1.53 Million. The most recent transaction as insider was on Mar 01, 2022, when has been sold 45,533 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 171K
0% 3M change
0% 12M change
Total Value Held $1.53 Million

Kristin Yarema Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 01 2022
BUY
Grant, award, or other acquisition
-
45,533 Added 20.99%
171,415 Common Stock
Jun 14 2021
BUY
Open market or private purchase
$469,798 $14.53 p/Share
32,333 Added 20.44%
125,882 Common Stock
Jun 11 2021
BUY
Open market or private purchase
$29,304 $14.5 p/Share
2,021 Added 2.11%
93,549 Common Stock
May 18 2021
SELL
Open market or private sale
$11,073 $14.55 p/Share
761 Reduced 0.82%
91,528 Common Stock
Mar 01 2021
BUY
Grant, award, or other acquisition
-
35,021 Added 27.51%
92,289 Common Stock

Also insider at

PSTX
Poseida Therapeutics, Inc. Healthcare
President and CEO
KY

Kristin Yarema

Chief Commercial Officer
South San Francisco, CA

Track Institutional and Insider Activities on ATRA

Follow Atara Biotherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATRA shares.

Notify only if

Insider Trading

Get notified when an Atara Biotherapeutics, Inc. insider buys or sells ATRA shares.

Notify only if

News

Receive news related to Atara Biotherapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ATRA